Rua Bioscience continues Australian expansion

2
nd
April 2024
FOR PUBLIC RELEASE
Rua Bioscience conƟnues Australian expansion.
TairawhiƟ, New Zealand – Rua Bioscience is conƟnuing to expand its offering in Australia, one of the
largest medicinal cannabis markets in the world.
With company licences and distribuƟon channels established in 2023, Rua successfully launched into
this key market last September with a dried flower product.
It has now extended the range with the introducƟon of full spectrum oil products and liquid
vaporisaƟon cartridges.
“Australia has always been an important focus for us,” said CEO Paul Naske.
“Now that we have a broader range of products available in Australia, we are well posiƟoned to
develop a strong sales presence and build the Rua brand there.”
This push into Australia is supported by Rua’s recent appointment of their first Australian-based Chief
of Sales and MarkeƟng, to drive growth and market share.
“Rua’s strategy is to commercialise our unique geneƟcs on a global scale,” added Mr Naske. “In the
coming months, we’re aiming to launch a range of medicinal cannabis products using our New
Zealand geneƟcs into the Australian market.”

ENDS
The person who authorised this announcement:

Paul Naske
Chief ExecuƟve Officer
paul.naske@ruabio.com
+64 21 445154

For media inquiries, please contact:
Paul Naske - paul.naske@ruabio.com